420 related articles for article (PubMed ID: 36274116)
1. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
Purohit P; Barik D; Agasti S; Panda M; Meher BR
J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
[TBL] [Abstract][Full Text] [Related]
3. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease.
Purohit P; Barik D; Dansana J; Meher BR
Comput Biol Chem; 2024 Feb; 108():108005. PubMed ID: 38157660
[TBL] [Abstract][Full Text] [Related]
4. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.
Bharadwaj S; Lee KE; Dwivedi VD; Yadava U; Panwar A; Lucas SJ; Pandey A; Kang SG
Sci Rep; 2019 Dec; 9(1):19059. PubMed ID: 31836806
[TBL] [Abstract][Full Text] [Related]
6. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
7. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
[TBL] [Abstract][Full Text] [Related]
8. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
Gurusamy M; Abdul JF
Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
[TBL] [Abstract][Full Text] [Related]
9. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
[TBL] [Abstract][Full Text] [Related]
11. Exploring allosteric hits of the NS2B-NS3 protease of DENV2 by structure-guided screening.
Gangopadhyay A; Saha A
Comput Biol Chem; 2023 Jun; 104():107876. PubMed ID: 37141792
[TBL] [Abstract][Full Text] [Related]
12. Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue.
Cheng J; Feng S; Zhang Y; Ding T; Jiang H; Zhang Z; Wang J; Wang X; Cheng M
Biochem Biophys Res Commun; 2022 Oct; 627():214-219. PubMed ID: 36058105
[TBL] [Abstract][Full Text] [Related]
13. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
14. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
15. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.
Hariono M; Choi SB; Roslim RF; Nawi MS; Tan ML; Kamarulzaman EE; Mohamed N; Yusof R; Othman S; Abd Rahman N; Othman R; Wahab HA
PLoS One; 2019; 14(1):e0210869. PubMed ID: 30677071
[TBL] [Abstract][Full Text] [Related]
16. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
Saqallah FG; Abbas MA; Wahab HA
Phytochemistry; 2022 Oct; 202():113362. PubMed ID: 35948138
[TBL] [Abstract][Full Text] [Related]
18. Antiviral phytochemicals as potent inhibitors against NS3 protease of dengue virus.
Rahman MM; Biswas S; Islam KJ; Paul AS; Mahato SK; Ali MA; Halim MA
Comput Biol Med; 2021 Jul; 134():104492. PubMed ID: 34022487
[TBL] [Abstract][Full Text] [Related]
19. Anti-dengue infectivity evaluation of bioflavonoid from
Dwivedi VD; Bharadwaj S; Afroz S; Khan N; Ansari MA; Yadava U; Tripathi RC; Tripathi IP; Mishra SK; Kang SG
J Biomol Struct Dyn; 2021 Mar; 39(4):1417-1430. PubMed ID: 32107969
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
